Ads
related to: CPRX
Search results
Catalyst (CPRX) Settles Patent Dispute Over Sole Marketed Drug
Zacks via Yahoo Finance· 2 years agoCatalyst (CPRX) settles patent litigation disputes related to Firdapse, its LEMS drug. This...
Catalyst (CPRX) Q4 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 3 months agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted diluted earnings of 53 cents per share for the...
Catalyst Pharmaceutical (CPRX) Crossed Above the 20-Day Moving Average: What That Means for...
Zacks via Yahoo Finance· 1 year agoAfter reaching an important support level, Catalyst Pharmaceutical (CPRX) could be a good stock pick...
Catalyst (CPRX) Seeks to Increase Maximum Daily Dose for Firdapse
Zacks via Yahoo Finance· 7 months agoThe FDA accepts Catalyst's (CPRX) sNDA to increase the indicated maximum daily dosage of Firdapse 10...
Catalyst Pharmaceuticals (CPRX) Rallies 43% YTD: Here's Why
Zacks via Yahoo Finance· 2 years agoCatalyst's (CPRX) price rallies on the back of the robust performance of its lead drug, Firdapse,...
Catalyst Pharma's (CPRX) sNDA for Firdapse Approved by the FDA
Zacks via Yahoo Finance· 2 years agoCatalyst Pharmaceuticals (CPRX) announces FDA approval of its sNDA for Firdapse to include pediatric...
Strength Seen in Catalyst (CPRX): Can Its 9.2% Jump Turn into More Strength?
Zacks via Yahoo Finance· 1 year agoCatalyst (CPRX) was a big mover last session on higher-than-average trading volume. The latest trend...
Are Investors Undervaluing Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) By 50%?
Simply Wall St. via Yahoo Finance· 1 year agoHow far off is Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) from its intrinsic value? Using the most...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who...
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock...
Catalyst's (CPRX) Q4 Earnings & Sales Top, Boosted by Firdapse
Zacks via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals (CPRX) reports better-than-expected financial performance as it beats both...